Outcomes of two versus three incision techniques: Results from the subcutaneous ICD post-approval study.
Abstract
BACKGROUND: Traditionally, implantation of the subcutaneous implantable cardioverter defibrillator (S-ICD) requires incisions near the lateral chest wall, the xyphoid, and the superior sternal region (three-incision technique [3IT]). A two-incision technique (2IT) avoids the superior incision and has been shown to be a viable alternative in small studies with limited follow-up.
OBJECTIVES: To report on the long-term safety and efficacy of the 2IT compared to the 3IT procedure in a large patient cohort.
METHODS: Patients enrolled in the S-ICD post approval study (PAS) were stratified by procedural technique (2IT vs. 3IT). Baseline demographics, comorbidities and procedural outcomes were collected. Complications and S-ICD effectiveness in treating ventricular arrhythmias through an average 3-year follow-up period were compared.
RESULTS: Of 1637 patients enrolled in the S-ICD PAS, 854 pts (52.2%) were implanted using the 2IT and 782 were implanted using the 3IT (47.8%). The 2IT became more prevalent over time, increasing from 40% to 69% of implants (Q1-Q4). Mean procedure time was shorter with 2IT (69.0 vs. 86.3 min, p < .0001). No other differences in outcomes were observed between the two groups, including rates of infection, electrode migration, inappropriate shocks and first shock efficacy for treating ventricular arrhythmias.
CONCLUSION: In this large cohort of patients implanted with an S-ICD and followed for 3 years the 2IT was as safe and effective as the 3IT while significantly reducing procedure time.
Document Type
Article
Publication Date
3-1-2021
Publication Title
Journal of cardiovascular electrophysiology
First Page
792
Last Page
801
Recommended Citation
El-Chami, Mikhael; Weiss, Raul; Burke, Martin C; Gold, Michael R; Prutkin, Jordan M; Kalahasty, Gautham; Shen, Sharon; Mirro, Michael J. MD; Carter, Nathan; and Aasbo, Johan D, "Outcomes of two versus three incision techniques: Results from the subcutaneous ICD post-approval study." (2021). Parkview Heart Institute. 11.
https://researchrepository.parkviewhealth.org/cardiol/11